Oppenheimer & Co’s Adient ADNT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADNT
BHG
LAM
DSA
LBA
Oppenheimer & Co's ADNT Position: Q4 2019 in Review
Oppenheimer & Co sold out of Adient (ADNT) in Q4 2019, closing a stake of 9,255 shares — an estimated $212K sold.
Oppenheimer & Co first reported a position in ADNT in Q4 2016 and held it in 12 quarters. The position peaked at $1.97M in Q3 2017. 315 funds tracked by Wall St. Rank hold ADNT as of Q4 2019.
- Oppenheimer & Co reported no remaining Adient position as of Q4 2019 after selling out during the quarter.
- Oppenheimer & Co sold 9,255 Adient shares in Q4 2019, an estimated $212K.
- Oppenheimer & Co first reported a position in Adient in Q4 2016 and held it in 12 quarters.
- Oppenheimer & Co's Adient position peaked at $1.97M in Q3 2017.
- 315 funds tracked by Wall St. Rank held Adient as of Q4 2019.
Based on Oppenheimer & Co's 13F filing for Q4 2019, filed 7 Feb 2020.